ScreenerHero

TLSIW TriSalus Life Sciences, Inc. - Warrant

NAS · US · Healthcare · Biotechnology · trisaluslifesci.com
0.8100USD+1.24%Mkt Cap: —P/E: —

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat live…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)45.08M USD
Gross Profit38.19M USD
Net Income (TTM)-39.23M USD
Revenue/Share0.90 USD
Last Price0.8100 USD
Fiscal Year End—
MR Quarter—
Employees102
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B4.69
EPS (TTM)—
EPS (Forward)—
52W Range
0.44108% of range5.000
52W High5.000 USD
52W Low0.4410 USD
Profitability
Gross Margin84.57%
Oper. Margin-86.03%
EBITDA Margin-66.44%
Profit Margin-86.88%
ROE115.85%
ROA-111.03%
Growth
Revenue Growth1.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.01M USD
CapEx (TTM)918.00K USD
FCF Margin-24.13%
FCF Yield—
Net Debt-11.86M USD
Net Debt/EBITDA0.40
Balance Sheet
Debt/Equity-1.02
Current Ratio5.35
Quick Ratio4.72
Book Value/Sh0.21 USD
Cash/Share0.75 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float49.82M
Insiders—
Institutions—
Technical
SMA 500.8785 (-7.8%)
SMA 2001.044 (-22.4%)
Beta0.47
S&P 52W Chg15.78%
Avg Vol (30d)3.37K
Avg Vol (10d)3.09K
Technical Indicators
RSI (14)46.9
MACD-0.0085
MACD Signal-0.0052
MACD Hist.-0.0033
BB Upper1.098 USD
BB Middle0.8530 USD
BB Lower0.6084 USD
BB Width57.35%
ATR (14)0.0990 USD
Vol Ratio (20d)1.68x